Longevity Health Holdings Inc (NASDAQ:XAGE) price on Thursday, May 22, rose 12.75% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $3.45.
A look at the stock’s price movement, the close in the last trading session was $3.06. Turning to its 52-week performance, $87.90 and $2.63 were the 52-week high and 52-week low respectively. Overall, XAGE moved -29.88% over the past month.
Longevity Health Holdings Inc’s market cap currently stands at around $3.46 million, with investors looking forward to this quarter’s earnings report slated for in June.
Turning to the stock’s technical picture we see that short term indicators suggest on average that XAGE is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
XAGE’s current price about -16.19% and -25.23% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 42.46, while 7-day volatility ratio is 12.80% and 10.69% in the 30-day chart. Further, Longevity Health Holdings Inc (XAGE) has a beta value of 0.58, and an average true range (ATR) of 0.77.
If we refocus on Longevity Health Holdings Inc (NASDAQ:XAGE), historical trading data shows that trading volumes averaged 242.84K over the past 3 months. The company’s latest data on shares outstanding shows there are 1.00 million shares.
The 24.70% of Longevity Health Holdings Inc’s shares are in the hands of company insiders while institutional holders own 6.96% of the company’s shares. Current price change has pushed the stock -58.80% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the XAGE stock continues to rise going into the next quarter.
